Information from the Hong Kong Stock Exchange reveals that on June 16, Executive Director Tang Minjie acquired 5,000 shares of Haohai Biotec (HKEX: 06826) at a price of HK$16.12 per share, involving a total sum of approximately HK$80,600.

Following this transaction, his latest shareholding stands at around 50,400 shares, representing a stake of 0.14% in the company.